NASDAQ:ABCM

Abcam (ABCM) Stock Forecast, Price & News

$16.90

+0.65 (+4.00%)

(As of 06/2/2023 ET)

Compare

Today's Range: $16.31
▼
$17.05
50-Day Range: $12.62
▼
$17.90
52-Week Range: $12.48
▼
$18.38

Volume: 1.34 million shs
Average Volume: 994,829 shs
Market Capitalization: $3.87 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $23.00

Abcam MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 36.1% Upside
$23.00 Price Target
Short Interest: Healthy
0.26% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.26
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 26.83%
From $0.41 to $0.52 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

189th out of 983 stocks

Biological Products, Except Diagnostic Industry

23rd out of 164 stocks

3.3

Analyst's Opinion

Consensus Rating
Abcam has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $23.00, Abcam has a forecasted upside of 36.1% from its current price of $16.90.
Amount of Analyst Coverage
Abcam has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.26% of the outstanding shares of Abcam have been sold short.
Short Interest Ratio / Days to Cover
Abcam has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Abcam has recently decreased by 15.17%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Abcam does not currently pay a dividend.
Dividend Growth
Abcam does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ABCM.

2.9

News and Social Media Coverage

News Sentiment
Abcam has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Abcam this week, compared to 1 article on an average week.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Abcam insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.73% of the stock of Abcam is held by insiders.
Percentage Held by Institutions
Only 13.91% of the stock of Abcam is held by institutions.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Abcam are expected to grow by 26.83% in the coming year, from $0.41 to $0.52 per share.
Price to Earnings Growth Ratio
Abcam has a PEG Ratio of 1.76. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Abcam has a P/B Ratio of 4.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Abcam (NASDAQ:ABCM) Stock

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCM Stock News Headlines

June 2, 2023 | americanbankingnews.com

Abcam (NASDAQ:ABCM) Sees Strong Trading Volume

May 30, 2023 | finance.yahoo.com

Jonathan Milner calls Extraordinary General Meeting to restore focus to Abcam on governance, execution, and cost control

June 3, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

May 29, 2023 | americanbankingnews.com

Abcam plc (NASDAQ:ABCM) Short Interest Update

May 13, 2023 | americanbankingnews.com

Abcam plc (NASDAQ:ABCM) Sees Large Increase in Short Interest

May 9, 2023 | markets.businessinsider.com

SVB Securities Keeps Their Buy Rating on Abcam (ABCM)

May 4, 2023 | msn.com

Abcam to streamline and consolidate operations in bid to cut costs

May 4, 2023 | finance.yahoo.com

Abcam, plc Business Update

June 3, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

May 4, 2023 | americanbankingnews.com

Abcam (NASDAQ:ABCM) Reaches New 12-Month High at $17.76

May 1, 2023 | americanbankingnews.com

Royal Bank of Canada Boosts Abcam (NASDAQ:ABCM) Price Target to $23.00

April 19, 2023 | americanbankingnews.com

Abcam (NASDAQ:ABCM) Sees Unusually-High Trading Volume

April 18, 2023 | americanbankingnews.com

Short Interest in Abcam plc (NASDAQ:ABCM) Declines By 25.4%

April 14, 2023 | nasdaq.com

Abcam (ABCM) Shares Cross Above 200 DMA

March 29, 2023 | americanbankingnews.com

Abcam plc (NASDAQ:ABCM) Sees Significant Growth in Short Interest

March 28, 2023 | finance.yahoo.com

ABCAM PLC: Final results for the year ended 31 December 2022

March 25, 2023 | americanbankingnews.com

Abcam plc Forecasted to Earn FY2023 Earnings of $0.40 Per Share (NASDAQ:ABCM)

March 24, 2023 | americanbankingnews.com

Abcam plc (NASDAQ:ABCM) to Post FY2023 Earnings of $0.45 Per Share, SVB Leerink Forecasts

March 22, 2023 | americanbankingnews.com

Abcam plc (NASDAQ:ABCM) to Post FY2024 Earnings of $0.51 Per Share, William Blair Forecasts

March 22, 2023 | americanbankingnews.com

Abcam plc to Post FY2024 Earnings of $0.51 Per Share, William Blair Forecasts (NASDAQ:ABCM)

March 21, 2023 | americanbankingnews.com

Contrasting Brookline Capital Acquisition (NASDAQ:BCAC) & Abcam (NASDAQ:ABCM)

March 10, 2023 | finance.yahoo.com

Abcam to Report Full Year Results on Monday, March 20, 2023

February 24, 2023 | finance.yahoo.com

Abcam plc (ABCM) Stock Historical Prices & Data - Yahoo Finance

December 14, 2022 | 247wallst.com

First Look Analysts Research Calls for Wednesday, December 14

November 11, 2022 | finance.yahoo.com

ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting

May 6, 2022 | nasdaq.com

Abcam - ADR (Sponsored) Shares Fall 0.6% Below Previous 52-Week Low - Market Mover

February 22, 2022 | nasdaq.com

Abcam Becomes Oversold (ABCM)

See More Headlines

ABCM Price History

30 days | 90 days | 365 days | Advanced Chart

ABCM Company Calendar

Today: 6/03/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ABCM
CUSIP: N/A
CIK: 1492074
Web: www.abcam.com
Phone: 44-0-12-2369-6000
Fax: N/A
Employees: 1,760
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $23.00
High Stock Price Forecast: $23.00
Low Stock Price Forecast: $23.00
Forecasted Upside/Downside: +36.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 41.22
P/E Growth: 1.76
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.27
Quick Ratio: 0.93

Sales & Book Value

Annual Sales: $447.49 million
Price / Sales: 8.66
Cash Flow: $0.62 per share
Price / Cash Flow: 27.24
Book Value: $3.92 per share
Price / Book: 4.31

Miscellaneous

Outstanding Shares: 229,270,000
Free Float: 213,842,000
Market Cap: $3.87 billion
Optionable: Not Optionable
Beta: 0.64

Key Executives

Mr. Alan Thomas Hirzel BS (Age 55)
M.B.A., M.S., MBA, MS, CEO & Exec. Director
Comp: $1.49M

Mr. Michael Shaun Baldock B.A. (Age 59)
CFO & Director
Comp: $1.06M

Mr. Mark Dermody
Interim CIO

James Staveley
VP of Investor Relations

Marc Perkins
Gen. Counsel & Company Sec.

Emma Sceats
Sr. VP of Sales, Service & Bus. Devel.

Mr. Nick Skinner
Sr. VP of HR

Mr. Mark Bushfield
Sr. VP of Research & Innovation

Ms. Kirstie Speck BBusSc
Head of Consumer Insights

Ms. Yvonne Chien
Sr. VP of Customer Experience

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

ABCM Stock - Frequently Asked Questions

Should I buy or sell Abcam stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ABCM shares.
View ABCM analyst ratings or view top-rated stocks.
What is Abcam's stock price forecast for 2023?: 2 brokers have issued 12 month target prices for Abcam's shares. Their ABCM share price forecasts range from $23.00 to $23.00. On average, they predict the company's stock price to reach $23.00 in the next year. This suggests a possible upside of 36.1% from the stock's current price.
View analysts price targets for ABCM or view top-rated stocks among Wall Street analysts.
How have ABCM shares performed in 2023?: Abcam's stock was trading at $15.56 at the beginning of 2023. Since then, ABCM shares have increased by 8.6% and is now trading at $16.90.
View the best growth stocks for 2023 here.
Are investors shorting Abcam?: Abcam saw a decrease in short interest in May. As of May 15th, there was short interest totaling 603,500 shares, a decrease of 15.2% from the April 30th total of 711,400 shares. Based on an average daily trading volume, of 731,700 shares, the short-interest ratio is currently 0.8 days.
View Abcam's Short Interest.
What ETFs hold Abcam's stock?: ETFs with the largest weight of Abcam (NASDAQ:ABCM) stock in their portfolio include BlackRock Future Health ETF (BMED), Invesco Nasdaq Biotechnology ETF (IBBQ), iShares Biotechnology ETF (IBB), ProShares Ultra Nasdaq Biotechnology (BIB),
What guidance has Abcam issued on next quarter's earnings?: Abcam updated its first quarter 2023 earnings guidance on Monday, April, 17th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $121.46 million-$121.46 million.

When did Abcam IPO?: (ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair served as the underwriters for the IPO.
What is Abcam's stock symbol?: Abcam trades on the NASDAQ under the ticker symbol "ABCM."
Who are Abcam's major shareholders?: Abcam's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (6.76%), Wellington Management Group LLP (6.39%), Harding Loevner LP (5.99%), Baillie Gifford & Co. (5.20%), Brown Capital Management LLC (4.25%) and Wasatch Advisors LP (3.55%).
How do I buy shares of Abcam?: Shares of ABCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Abcam's stock price today?: One share of ABCM stock can currently be purchased for approximately $16.90.
How much money does Abcam make?: Abcam (NASDAQ:ABCM) has a market capitalization of $3.87 billion and generates $447.49 million in revenue each year.
How many employees does Abcam have?: The company employs 1,760 workers across the globe.
How can I contact Abcam?: The official website for the company is www.abcam.com. The company can be reached via phone at 44-0-12-2369-6000 or via email at investor.relations@abcam.com.

This page (NASDAQ:ABCM) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial